ECS
ECS BOTANICS HOLDINGS LTD
$0.0050
0.00%
Market cap
$8M
Turnover
$9,336
Last price
$0.0050
Day change
0.00%
Announcements
7
Range, past year
Open 0.007 · Low 0.003 · Now 0.005 · High 0.013
Open ECS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
ECS momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
21/100
Wyckoff phase
Downtrend3d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
-16.7%
1 Month
-16.7%
1 Year
-16.7%
RSI
34
Avg daily range
10.9%
ECS BOTANICS HOLDINGS LTD scores 21 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 3 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -28.6%
- High volatility (ATR 10.9%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsECS announcements
Recent price-sensitive releases.
- 2026-08-28 ECS FY26 Results Preliminary Final Report | Periodic Reports - Other
- 2026-08-28 Appendix 4E & Annual Report Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-27 ECS launches All-In-One Vapes Progress Report | Company Administration - Other
- 2026-07-20 Quarterly Activities/Appendix 4C Cash Flow Report
- 2026-07-03 German GMP Update Reinforces ECS Manufacturing Strategy
- 2026-06-22 ECS Launches First Australian-Grown Terphogz Product
- 2026-04-28 Quarterly Activities/Appendix 4C Cash Flow Report
More Health Care stocks
Most traded in the same sector.